Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 06 Jan 2025 14:57 CET |
THOR MEDICAL ASA | Thor Medical ASA: Completion of extraordinary general meeting | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 20 Dec 2024 15:06 CET |
THOR MEDICAL ASA | Thor Medical ASA: Notification of trade for close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 20 Dec 2024 14:26 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 20 Dec 2024 14:23 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholdings and notification of transaction by close associates of primary insiders | 20103010 Biotechnology | Major shareholding notifications |
| 20 Dec 2024 14:17 CET |
THOR MEDICAL ASA | Thor Medical ASA - Share capital increase in relation to Tranche 1 of the Private Placement and the PrimaryBid Offering is registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 19 Dec 2024 07:45 CET |
THOR MEDICAL ASA | Thor Medical and AdvanCell sign strategic supply agreement for Thorium-228 | 20103010 Biotechnology | Inside information |
| 16 Dec 2024 20:34 CET |
THOR MEDICAL ASA | Thor Medical ASA - Notice of Extraordinary General Meeting on 6 January 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA: Ex. right to participate in subsequent offering today | 20103010 Biotechnology | Ex Date |
| 12 Dec 2024 00:59 CET |
THOR MEDICAL ASA | Thor Medical ASA: Disclosure of large shareholding - share lending | 20103010 Biotechnology | Major shareholding notifications |
| 12 Dec 2024 00:55 CET |
THOR MEDICAL ASA | Thor Medical ASA: Allocation of shares to primary insiders and their close associates in the Private Placement | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 12 Dec 2024 00:43 CET |
THOR MEDICAL ASA | Thor Medical ASA: Key information relating to potential subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2024 00:31 CET |
THOR MEDICAL ASA | Thor Medical ASA: Private placement successfully completed | 20103010 Biotechnology | Inside information |
| 11 Dec 2024 16:30 CET |
THOR MEDICAL ASA | Thor Medical ASA: Contemplated private placement and retail offer via PrimaryBid | 20103010 Biotechnology | Inside information |
| 25 Nov 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical capital markets update: Enabling next-generation precision cancer treatments | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Nov 2024 07:45 CET |
THOR MEDICAL ASA | Thor Medical signs agreement for supply of Pb-212 for pre-clinical use with globally leading pharmaceutical company | 20103010 Biotechnology | Inside information |
| 20 Nov 2024 07:30 CET |
THOR MEDICAL ASA | Reminder: Thor Medical invitation to capital markets update 25 November 2024 | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 19 Nov 2024 07:30 CET |
THOR MEDICAL ASA | Thor Medical ships first product sample to potential customer from Herøya pilot facilities | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Nov 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical invitation to capital markets update | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Oct 2024 07:30 CET |
THOR MEDICAL ASA | Thor Medical and ARTBIO sign strategic long-term supply agreement for Thorium-228 | 20103010 Biotechnology | Inside information |
| 30 Sep 2024 21:34 CEST |
THOR MEDICAL ASA | Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 26 Sep 2024 08:00 CEST |
THOR MEDICAL ASA | Thor Medical completes Herøya pilot facilities and initiates commissioning | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Aug 2024 07:00 CEST |
THOR MEDICAL ASA | Thor Medical ASA reports first half 2024 results - Pilot facility progressing as planned and targeting 'fast-track' scale-up to commercial production | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2024 07:00 CEST |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's first half results 2024 | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Aug 2024 18:32 CEST |
THOR MEDICAL ASA | Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 01 Aug 2024 07:30 CEST |
THOR MEDICAL ASA | Jasper Kurth has assumed the position as CEO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Jun 2024 07:30 CEST |
THOR MEDICAL ASA | Thor Medical receives DSA authorization for production of alpha-emitters at Herøya pilot plant | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Jun 2024 08:00 CEST |
THOR MEDICAL ASA | Thor Medical releases updated investor presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Jun 2024 08:00 CEST |
THOR MEDICAL ASA | Thor Medical signs Memorandum of Understanding for feedstock supply and technology cooperation | 20103010 Biotechnology | Non-regulatory press releases |
| 06 May 2024 15:05 CEST |
THOR MEDICAL ASA | Primary insider trading | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 02 May 2024 13:59 CEST |
THOR MEDICAL ASA | New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Apr 2024 17:00 CEST |
THOR MEDICAL ASA | Share option grant | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 21 Apr 2024 12:20 CEST |
THOR MEDICAL ASA | Grant of restricted stock units (RSU) to the members of the board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Apr 2024 12:17 CEST |
THOR MEDICAL ASA | Issuance of shares to members of the board | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 11 Apr 2024 21:07 CEST |
THOR MEDICAL ASA | Minutes from the annual general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Apr 2024 14:45 CEST |
THOR MEDICAL ASA | Completion of annual general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Apr 2024 16:30 CEST |
THOR MEDICAL ASA | Business update from CEO in relation to the company's AGM | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Apr 2024 17:21 CEST |
THOR MEDICAL ASA | Flagging Thor Medical ASA 08.04.2024 | 20103010 Biotechnology | Major shareholding notifications |
| 03 Apr 2024 21:12 CEST |
THOR MEDICAL ASA | Thor Medical ASA – Mottatte stemmefullmakter til ordinær generalforsamling 2024 | 20103010 Biotechnology | Flagging |
| 03 Apr 2024 21:08 CEST |
THOR MEDICAL ASA | Thor Medical ASA - Mottatte stemmefullmakter til ordinær generalforsamling 2024 | 20103010 Biotechnology | Flagging |
| 02 Apr 2024 15:52 CEST |
THOR MEDICAL ASA | Flagging Thor Medical ASA 02.04.2024 | 20103010 Biotechnology | Flagging |
| 21 Mar 2024 09:19 CET |
THOR MEDICAL ASA | Thor Medical ASA - Notice of Annual General Meeting on 11 April 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Mar 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical publishes Annual Report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
| 14 Mar 2024 08:17 CET |
THOR MEDICAL ASA | Thor Medical ASA receives Innovation Norway grant for lab and pilot facilities at Herøya | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Mar 2024 07:30 CET |
THOR MEDICAL ASA | THOR MEDICAL ASA EMPLOYS BREDE ELLINGSÆTER AS CFO | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 28 Feb 2024 07:00 CET |
THOR MEDICAL ASA | Thor Medical ASA reports 2023 results - current focus on establishing pilot plant | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 21 Feb 2024 08:03 CET |
THOR MEDICAL ASA | Invitation to presentation of Thor Medical ASA's second half results 2023 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Feb 2024 07:30 CET |
THOR MEDICAL ASA | THOR MEDICAL EMPLOYS JASPER KURTH AS NEW CEO | 20103010 Biotechnology | Inside information |
| 19 Jan 2024 16:27 CET |
THOR MEDICAL ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Dec 2023 12:40 CET |
THOR MEDICAL ASA | Thor Medical ASA builds lab and pilot facilities at Herøya as key milestones towards industrial-scale production of alpha emitters | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Nov 2023 20:06 CET |
THOR MEDICAL ASA | Thor Medical signs agreement to transfer its Nordic Nanovector patents to NucliThera | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |